• Health & Medicine

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England 

The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma. The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.

20 August 2020

• Health & Medicine

The team tackling the serious side effects of cancer treatment in an ageing population

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer. We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.

19 August 2020

• Health & Medicine

US lung cancer data points to the power of cancer research

New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer. New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.

18 August 2020

• Health & Medicine

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go. The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

11 August 2020

• Health & Medicine

One third of cancer patients say coronavirus has impacted their treatment

One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results. One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results.

28 July 2020

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• Health & Medicine

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

15 July 2020

• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Health & Medicine

Prostate cancer hormone therapy not recommended for NHS in England

A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.

26 June 2020

• Health & Medicine

Targeted drug improves survival for children with non-Hodgkin lymphoma

New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma. New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.

25 June 2020

• Health & Medicine

Cancer blood test uses 'noise cancellation' to improve sensitivity

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods. Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

18 June 2020

• Health & Medicine

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer. A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

5 June 2020